Why subclinical involvement is prescribed the same high dose as gross tumor volume: A study on high‐dose clinical target volume in intensity‐modulated radiotherapy plan of nasopharyngeal carcinoma

Author:

Qiu Zichen1ORCID,Lin Feifei1ORCID,Wu Zheng2,Wu Taihua3,Wang Mingli1,Hu Jiang1,Xie Dehuan4,Lyu Shaowen5,Ma Jun1,Tao Yalan1,Su Yong1ORCID

Affiliation:

1. Department of Radiation Oncology Sun Yat‐sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Guangzhou China

2. Department of Radiation Oncology, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine Central South University Changsha China

3. School of Computer Science Zhuhai College of Science and Technology Zhuhai China

4. Department of Radiation Nasopharyngeal Carcinoma Sun Yat‐sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Guangzhou China

5. Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology Maastricht University Medical Center Maastricht The Netherlands

Abstract

AbstractBackgroundMost nasopharyngeal carcinoma (NPC) protocols define primary gross tumor volume (GTVnx) plus a range from 2 to 5 mm as the high‐dose clinical target volume (hd‐CTV). However, in China, hd‐CTV is defined as GTVnx plus 0 mm.MethodsA total of 40 patients with newly diagnosed nonmetastatic NPC (T1–T4 ten cases each) treated with IMRT were consecutively enrolled. Real and virtual treatment plans were designed according to the definitions of hd‐CTV recommended by China and Radiation Therapy Oncology Group (RTOG), respectively.ResultsThe hd‐CTV in China was significantly smaller than that of RTOG. Exposure doses to 5 mm subclinical involvement and OARs as well as NTCP in the China treatment plan were significantly lower than those of RTOG.ConclusionIt could be recommended to divide the hd‐CTV into GTV and subclinical target volume and to prescribe different doses for the GTV and subclinical involvement in the IMRT plan of NPC.

Publisher

Wiley

Subject

Otorhinolaryngology

Reference42 articles.

1. Prescribing recording and reporting photon beam therapy. International Commission on Radiation Units and Measurements (ICRU) report 50; 1993.

2. Prescribing Recording and Reporting Photon Beam Therapy. International Commission on Radiation Units and Measurements (ICRU) report 62 (Supplement to ICRU 50); 1999.

3. Prescribing recording and reporting electron beam therapy. International Commission on Radiation Units and Measurements (ICRU) report 71; 2004.

4. Prescribing Recording and Reporting Proton‐Beam Therapy. International Commission on Radiation Units and Measurements (ICRU) report 78; 2007.

5. Prescribing recording and reporting intensity‐modulated photon‐beam therapy (IMRT). International Commission on Radiation Units and Measurements (ICRU) report 83; 2010.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3